Imax Corp Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $416.1M+18.1% YoYTTM through 30 Jun 2026
Net Income $40.9M+57.0% YoYTTM through 30 Jun 2026
Free Cash Flow $126.6MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 56.3% |
| EBITDA Margin | 35.2% |
| Operating Margin | 20.2% |
| Net Margin | 9.8% |
Returns
11.5%ROE
4.5%ROA
Balance Sheet Health
Cash & Equivalents$159.9M
Quality Metrics
Piotroski F-Score6 / 9
FCF Margin30.4%
Rule of 4037.2
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $410.2M
Diluted EPS$0.73TTMFY2025: $0.63
Dividend
No dividend
Capital Allocation
R&D Spend$6.4M
Capex Intensity1.5%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.